Prevalence of Frailty Among People Aged 75 and Over Living at Home
NCT ID: NCT05163457
Last Updated: 2022-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2022-01-06
2022-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The SEGAm showed its usefulness in aged patients living at home.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening for Frailty at Home
NCT02852200
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
NCT03326635
Identification of Frailty Predictors of Adverse Health Outcomes in Community-dwelling Individuals Aged 50 and Over
NCT04603144
The State of Play in Picardy of the Knowledge of the Elderly at Risk of Falling at Home in Terms of Prevention and Evaluation.
NCT03132857
Validation of a Record-based Frailty Assessment According to the Multidimensional Prognostic Index
NCT03794674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
aged of 75 and more living at home
aged of 75 and more living at home" group: patients aged of 75 and more living at home
Data collection
frailty evaluation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
frailty evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged of 75 and more
* living at home
* agreeing to participate in the study
Exclusion Criteria
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maison de Santé Pluridisciplinaire de Bar sur Seine
Bar-sur-Seine, Grand Est, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-012-FRAIL-DOM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.